Delineate
YC W25Boston, US · Founded 2024 · 20 employees · 2 known investors
Delineate builds AI agents that help pharmaceutical companies design clinical trials more quickly by converting existing trial research into specialized datasets, reducing the time scientists spend on trial preparation.
AI & Machine LearningBiotechDeveloper ToolsEnterprise SoftwareSaaSAIUnited States of AmericaAmerica / CanadaFully Remote
Founders & leadership· Y Combinator alumni (W25)
Delineate was founded in 2024 by Emily Nieves and Jawad Iqbal.
EN
Emily NievesinCo-Founder & CEOShe completed doctoral studies in biological engineering at MIT and previously worked as a scientist at Pfizer and AstraZeneca, where she developed AI methods for drug modeling and simulation.
JI
Jawad IqbalinCo-Founder @ Delineate | YC-W25Jawad Iqbal holds a master's degree in robotics and AI with published research, and previously worked as a technical project manager on digital transformation initiatives within Lockheed Martin's advanced development division.
Investors · 2
In the news
Frequently asked questions
- What does Delineate do?
- Delineate builds AI agents that help pharmaceutical companies design clinical trials more quickly by converting existing trial research into specialized datasets, reducing the time scientists spend on trial preparation.
- Who founded Delineate?
- Delineate was founded by Emily Nieves, Jawad Iqbal in 2024.
- Who are Delineate's investors?
- Delineate's investors include Civilization Ventures Management, Llc, Y Combinator.
- Where is Delineate headquartered?
- Delineate is headquartered in Boston, US.